1 report

KOL Perspectives: Perceptions of recent & upcoming data for key HBV pipeline agents Summary This KOL Insight briefing focuses on KOLs views of recent & upcoming data for key HBV pipeline agents. Questions topics - - Further Phase I data required for Roche’s capsid inhibitor RO7049389 -...

  • Pharmaceutical
  • RNAi Technology
  • United States
  • European Union
  • North America
  • World
  • Europe